FDA Inspection 1119692 — John Theurer Cancer Center At Hackensack University Medical Center

John Theurer Cancer Center At Hackensack University Medical Center — FEI 3016409550

The FDA completed an inspection of John Theurer Cancer Center At Hackensack University Medical Center on Feb 25, 2020 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 25, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hackensack, NJ (United States)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.